HomeAmisulprideAmisulpride + Droperidol

Does Amisulpride Interact with Droperidol?

Amisulpride and Droperidol have a contraindicated drug interaction according to U.S. FDA drug labeling data. AMISULPRIDE causes QT prolongation. Avoid use of AMISULPRIDE in patients taking droperidol to avoid potential additive effects. The mechanism involves additive qt prolongation. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Contraindicated
Amisulpride Class
Dopamine-2 Receptor Antagonist
Droperidol Class
Dopamine-2 Receptor Antagonist
Management
Do not take together
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Amisulpride and Droperidol occurs because additive qt prolongation. Clinically, this means amisulpride causes qt prolongation. avoid use of amisulpride in patients taking droperidol to avoid potential additive effects. Because of the severity of this interaction, these medications are contraindicated — meaning they should not be taken together under any circumstances. If you are currently taking both, contact your healthcare provider immediately to discuss alternatives.

What To Tell Your Doctor or Pharmacist

If you are taking Amisulpride and your doctor is considering prescribing Droperidol (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask about alternative medications that do not interact with your current regimen
  • Ask how frequently you should be monitored while these are co-prescribed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Amisulpride(Barhemsys)+💊 Droperidol(Droperidol)

Severity & Interaction Details

contraindicated
Avoid this combination
FDA labeling lists this pair as contraindicated. The risk outweighs the benefit in nearly all cases.
Severity scale
MinorContra
On record
Yes
Drug A class
Dopamine-2 Receptor Antagonist
Drug B class
Dopamine-2 Receptor Antagonist
Source
NLP:amisulpride

What this means in plain English

AMISULPRIDE causes QT prolongation. Avoid use of AMISULPRIDE in patients taking droperidol to avoid potential additive effects.

About Amisulpride and Droperidol

Amisulpride and Droperidol both belong to the Dopamine-2 Receptor Antagonist class. Amisulpride is also sold under the brand name Barhemsys. Amisulpride is given by intravenous (IV) infusion, whereas Droperidol is given by intramuscular injection. Droperidol additionally carries an FDA boxed warning, the FDA's strongest safety alert.

What the FDA label says

"Additive QT prolongation"

📖 Source: NLP:amisulpride

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Amisulpride and Droperidol against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.